News

Qvintip on Facebook

Qvintip is now on Facebook! Please Like us on www.facebook.com/qvintip

Qvintip in Lithuania

Qvintip started to be delivered to Lithuania and is now available on the market through laboratory chains

Qvintip in Siberia.

Aprovix will present Qvintip in Siberia to Russia’s leading gynecologists.

Qvintip symposium in Moscow

In the frame of Cervical Cancer International Forum, Moscow Radisson Slavyanskaya, Aprovix CEO Lana Obolenskaja presented the Qvintip solution in front of leading Russian and International experts

Aprovix appoints new CEO.

Lana Obolenskaja, has been appointed as CEO of Aprovix AB. Lana has a background from management positions in marketing and regulatory affairs in pharmaceutical industry. Lana takes over the role from Bengt Falk, PhD, who will continue his engagement in the company as Chairman of the board.

New investors subscribes to Aprovix share issue.

A group of Finnish private investors have subscribed to new shares in a directed share issue, thereby securing financial resources for investment in primarily marketing and sales, as well as further product development.

Aprovix elects new board

During the annual shareholders meeting in October, following the share issue, Aprovix shareholders unanimously elected a new board, now consisting of Bengt Falk, Chairman, Leena Niemistö and Ariel Nemes representing the new investors in the company, as well as re-electing Sven Mattsson.

Menu